The alEC is particularly vulnerable to the effects of aging (Olsen et al., 2017; Reagh et al., 2018) and preclinical AD (Khan et al., 2014), which has been proposed to be due to its early susceptibility to tau pathology. The gene discussed is MAPT; the disease is Alzheimer disease.